Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

An immune control model for viral replication in the CNS during presymptomatic HIV infection.

McCrossan M, Marsden M, Carnie FW, Minnis S, Hansoti B, Anthony IC, Brettle RP, Bell JE, Simmonds P.

Brain. 2006 Feb;129(Pt 2):503-16. Epub 2005 Nov 29.

PMID:
16317019
2.

Do HIV disease progression and HAART response vary among injecting drug users in Europe?

van Asten L, Zangerle R, Hernández Aguado I, Boufassa F, Broers B, Brettle RP, Roy Robertson J, McMenamin J, Coutinho RA, Prins M.

Eur J Epidemiol. 2005;20(9):795-804.

PMID:
16170664
3.

Does drug abuse influence the microglial response in AIDS and HIV encephalitis?

Arango JC, Simmonds P, Brettle RP, Bell JE.

AIDS. 2004 Jan 1;18 Suppl 1:S69-74.

PMID:
15075500
4.

Delayed diagnosis of HIV infection in ophthalmic practice.

Wadood AC, Dhillon B, McIlwaine G, Brettle RP.

Eye (Lond). 2004 Mar;18(3):293-8.

PMID:
15004580
5.

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S; European and Italian Seroconverter Studies.

J Infect Dis. 2004 Jan 15;189(2):292-302. Epub 2004 Jan 8.

PMID:
14722895
6.

Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.

van Asten LC, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Hernández Aguado I, McMenamin J, Zangerle R, Fontanet A, Coutinho RA, Prins M.

Eur J Public Health. 2003 Dec;13(4):347-9.

PMID:
14703322
7.

Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion.

van Asten L, Langendam M, Zangerle R, Hernández Aguado I, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Fontanet A, Coutinho RA, Prins M.

AIDS. 2003 May 23;17(8):1201-8.

PMID:
12819522
8.

HIV and drug misuse in the Edinburgh cohort.

Bell JE, Arango JC, Robertson R, Brettle RP, Leen C, Simmonds P.

J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S35-42. Review.

PMID:
12394781
9.
10.

Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission.

Lockett SF, Robertson JR, Brettle RP, Yap PL, Middleton D, Leigh Brown AJ.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):277-80.

PMID:
11464148
11.

Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997.

Op de Coul EL, Prins M, Cornelissen M, van der Schoot A, Boufassa F, Brettle RP, Hernández-Aguado L, Schiffer V, McMenamin J, Rezza G, Robertson R, Zangerle R, Goudsmit J, Coutinho RA, Lukashov VV; European and Italian Seroconverter Studies.

AIDS. 2001 Jan 26;15(2):257-66.

PMID:
11216936
12.

Historical HIV prevalence in Edinburgh Prison: a database-linkage study.

Seaman SR, Bird SM, Brettle RP.

J Epidemiol Biostat. 2000;5(4):245-50.

PMID:
11055274
13.

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, Barton SE, Sudre P, Phillips AN.

Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):865-72. Erratum in: Am J Respir Crit Care Med. 2003 Jun 15;167(12):1719.

PMID:
10988097
14.

Injecting drug users in Edinburgh have a high rate of recidivism.

Seaman SR, Gore SM, Brettle RP.

Addiction. 2000 May;95(5):791-2. No abstract available.

PMID:
10885053
15.

Study requirements for investigating HLA-associated progression of HIV disease, and review.

Gore SM, Hutchinson SJ, Brettle RP.

QJM. 1999 Oct;92(10):609-17. No abstract available.

PMID:
10627883
16.

Do gender differences in CD4 cell counts matter?

Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

AIDS. 1999 Dec 3;13(17):2361-4.

PMID:
10597777
17.

Localized Mycobacterium avium intracellulare psoas abscess in patients with AIDS after antiretroviral therapy.

Boyd AE, Brettle RP.

AIDS. 1999 Oct 22;13(15):2185-6. No abstract available.

PMID:
10546883
19.

Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.

Lockett SF, Alonso A, Wyld R, Martin MP, Robertson JR, Gore SM, Leen CL, Brettle RP, Yirrell DL, Carrington M, Brown AJ.

J Infect Dis. 1999 Sep;180(3):614-21.

PMID:
10438347
20.

Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?

Prins M, Brettle RP, Robertson JR, Hernández Aguado I, Broers B, Carré N, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

Int J Epidemiol. 1999 Jun;28(3):541-9.

PMID:
10405862
21.

Hepatitis C: universal or selective screening?

Brettle RP.

Sex Transm Infect. 1998 Oct;74(5):374-5. Review. No abstract available.

22.

Spinal cord pathology and viral burden in homosexuals and drug users with AIDS.

Shepherd EJ, Brettle RP, Liberski PP, Aguzzi A, Ironside JW, Simmonds P, Bell JE.

Neuropathol Appl Neurobiol. 1999 Feb;25(1):2-10.

PMID:
10194770
23.

Cardiac autoimmunity in HIV related heart muscle disease.

Currie PF, Goldman JH, Caforio AL, Jacob AJ, Baig MK, Brettle RP, Haven AJ, Boon NA, McKenna WJ.

Heart. 1998 Jun;79(6):599-604.

24.

The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.

Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC.

Eur J Gastroenterol Hepatol. 1998 Jun;10(6):485-9.

PMID:
9855064
25.

HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

Bell JE, Brettle RP, Chiswick A, Simmonds P.

Brain. 1998 Nov;121 ( Pt 11):2043-52.

PMID:
9827765
28.

Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study Group.

Kirk O, Mocroft A, Katzenstein TL, Lazzarin A, Antunes F, Francioli P, Brettle RP, Parkin JM, Gonzales-Lahoz J, Lundgren JD.

AIDS. 1998 Oct 22;12(15):2031-9.

PMID:
9814872
29.

Heterosexual transmission of HIV in men and women in a Scottish cohort.

Robertson JR, Wyld R, Elton R, Brettle RP.

AIDS. 1998 May 7;12(7):823-4. No abstract available.

PMID:
9619819
30.
31.

Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients.

Brettle RP, Wilson A, Povey S, Morris S, Morgan R, Leen CL, Hutchinson S, Lewis S, Gore S.

Int J STD AIDS. 1998 Feb;9(2):80-7.

PMID:
9506372
32.
33.

Predicting survival in AIDS: refining the model.

Hutchinson SJ, Brettle RP, Gore SM.

QJM. 1997 Nov;90(11):685-92.

PMID:
9474349
34.

Pre-AIDS deaths in HIV infection related to intravenous drug use.

Brettle RP, Chiswick A, Bell J, Busuttil A, Wilson A, Povey S, Leen CL.

QJM. 1997 Oct;90(10):617-29.

PMID:
9415343
35.

Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.

Prins M, Hernández Aguado IH, Brettle RP, Robertson JR, Broers B, Carré N, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

AIDS. 1997 Nov 15;11(14):1747-56.

PMID:
9386810
36.

Has the rate of progression to AIDS changed in recent years?

Carré N, Prins M, Meyer L, Brettle RP, Robertson JR, McArdle H, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A.

AIDS. 1997 Nov;11(13):1611-8.

PMID:
9365766
37.

Pre-AIDS mortality in the Edinburgh City Hospital HIV cohort.

Seaman SR, Brettle RP, Gore SM.

Stat Med. 1997 Nov 15;16(21):2459-74.

PMID:
9364654
38.

Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.

Wyld R, Robertson JR, Brettle RP, Mellor J, Prescott L, Simmonds P.

J Infect. 1997 Sep;35(2):163-6.

PMID:
9354351
39.

Correlation between total and CD4 lymphocyte counts in HIV infection.

Brettle RP.

Int J STD AIDS. 1997 Sep;8(9):597. No abstract available.

PMID:
9292352
40.

The molecular epidemiology of human immunodeficiency virus type 1 in six cities in Britain and Ireland.

Brown AJ, Lobidel D, Wade CM, Rebus S, Phillips AN, Brettle RP, France AJ, Leen CS, McMenamin J, McMillan A, Maw RD, Mulcahy F, Robertson JR, Sankar KN, Scott G, Wyld R, Peutherer JF.

Virology. 1997 Aug 18;235(1):166-77.

41.

Mycobacterium avium intracellulare infection in patients with HIV or AIDS.

Brettle RP.

J Antimicrob Chemother. 1997 Aug;40(2):156-60. Review. No abstract available.

PMID:
9301979
42.

Effect of CMV serology and CMV disease on AIDS morbidity and mortality.

Laing RB, Brettle RP, Leen CL.

Infection. 1997 Jul-Aug;25(4):255. No abstract available.

PMID:
9266268
43.

Central venous catheters in patients with AIDS.

Goodman HE, Brettle RP, Stevenson B, Hamilton B, Kalima P, Leen CL.

Int J STD AIDS. 1997 Jul;8(7):417-22.

PMID:
9228587
44.

British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals.

Brettle RP, Burns SB, Povey S, Leen CL, Welsby PD.

Lancet. 1997 Jun 21;349(9068):1837-8. No abstract available.

PMID:
9269232
45.

Diagnostic utility of bone marrow sampling in HIV positive patients.

Brettle RP.

Genitourin Med. 1997 Apr;73(2):85-6. No abstract available.

46.

Hospital and hospice resource use of HIV-positive patients in Edinburgh.

Brettle RP, Atkinson FI, Wilcock J, Richardson A, Lewis R, MacCullum L, Bath G.

Int J STD AIDS. 1997 Apr;8(4):234-42.

PMID:
9147156
47.

CD4 and total lymphocyte count.

Brettle RP.

QJM. 1997 Feb;90(2):155. No abstract available.

PMID:
9068809
48.

The Internet and medicine: related sites including HIV/AIDS.

Brettle RP.

Int J STD AIDS. 1997 Feb;8(2):71-7. Review.

PMID:
9061404
49.

The cost of health care for HIV-positive patients.

Brettle RP, Atkinson FI, Wilcock J, Richardson A, Lewis R, MacCallum L, Bath G.

Int J STD AIDS. 1997 Jan;8(1):50-3.

PMID:
9043982
50.

Bacterial infections in HIV: the extent and nature of the problem.

Brettle RP.

Int J STD AIDS. 1997 Jan;8(1):5-15. Review.

PMID:
9043975

Supplemental Content

Loading ...
Support Center